April 1, 2016

Managed Care

Payers Sued Over Coverage of Expensive Hepatitis C Drugs

By Ed Silverman

As outrage over the potent, but pricey hepatitis C treatments escalates, payers are feeling the heat. Concerned that patients face harmful coverage restrictions, a fresh crop of lawsuits was recently filed by consumers against both insurers and the Medicaid program in the state of Washington. At the same time, the New York Attorney General accelerated an investigation of several carriers over the issue.

read full article >